Renal Klotho controls mineral metabolism by directly modulating tubular reabsorption of phosphate and calcium and by acting as a co-receptor for the phosphaturic and vitamin D-regulating hormone fibroblast growth factor-23 (FGF23). Klotho null mice have a markedly abnormal phenotype. We sought to determine effects of renal-specific and partial deletion of Klotho to facilitate investigation of its roles in health and disease. We generated a mouse model with partial deletion of Klotho in distal tubular segments (Ksp-KL 2/2 ).
phatemic with elevated FGF23 levels and abundant expression of the sodium-phosphate cotransporter Npt2a at the brush border membrane. Serum calcium and 1,25-dihydroxyvitamin D 3 levels were normal but parathyroid hormone levels were decreased. TRPV5 protein was reduced with a parallel mild increase in urinary calcium excretion. Renal expression of vitamin D regulatory enzymes and vitamin D receptor was higher in Ksp-KL 2/2 mice than controls, suggesting increased turnover of vitamin D metabolites and a functional increase in vitamin D signaling. There was a threshold effect of residual renal Klotho expression on FGF23: deletion of .70% of Klotho resulted in FGF23 levels 30-250 times higher than in wild-type mice.
A subgroup of Ksp-KL 2/2 mice with normal phosphate levels had elevated FGF23, suggesting a Klothoderived renal-bone feedback loop. Taken together, renal FGF23-Klotho signaling, which is disrupted in CKD, is essential for homeostatic control of mineral metabolism. Type I membrane-bound a-Klotho (Klotho) is expressed in tissues requiring abundant calcium transport, such as the kidneys and parathyroid glands. It was originally described as a senescencerelated protein, because mice lacking functional Klotho protein develop a syndrome resembling human aging, including shortened life span, atherosclerosis, vascular calcification, and osteoporosis. 1 Klotho regulates mineral metabolism by promoting renal calcium reabsorption through stabilization of the transient receptor potential vanilloid-5 (TRPV5) channel in distal tubules 2 and inhibits inorganic phosphate reabsorption through decreased expression and activity of the sodium-dependent phosphate cotransporter type 2a and c (Npt2a, Npt2c) in proximal tubules. 3 Furthermore, Klotho forms a specific receptor complex with fibroblast growth factor receptor 1c (FGFR1c) that transmits signaling of the circulating hormone FGF23. 4 Renal FGF23-Klotho signaling leads to internalization of Npt2a and Npt2c [5] [6] [7] and alterations in Cyp27B1 and Cyp24A1 transcripts encoding regulatory enzymes in vitamin D metabolism. 8 At the systemic level, this translates into a reduction of serum phosphate and 1,25-dihydroxyvitamin D 3 (1,25(OH) 2 
D).
The importance of Klotho as a renal coreceptor for FGF23 is evidenced by Klotho and Fg23 null mice that share nearly identical biochemical phenotypes consistent with dismantled FGF23 signaling, including hyperphosphatemia, elevated 1,25 (OH) 2 D, and hypercalcemia. 1, 9 Notably, the aging characteristics of Klotho and Fgf23 null mice are attenuated by dietary restrictions of phosphate and/or 1,25(OH) 2 D, or by eliminating vitamin D effects through ablation of its receptor (VDR) or the enzyme responsible for its activation (Cyp27B1). [10] [11] [12] [13] Collectively, this suggests that the aging phenotype is due to both systemic toxicity of mineral metabolites and perturbed FGF23-Klotho signaling.
The FGF23 level gradually increases during progression of CKD, whereas expression of Klotho decreases. 14, 15 Disturbances in FGF23-Klotho activity presumably contribute to the accelerated aging process and cardiovascular disease evident in CKD patients. 16, 17 Given the profound phenotype of Klotho null mice, we wanted to determine the effect of a renalspecific and partial deletion of Klotho. Such a model would shed light on several issues, including dose-dependent effects and kidney-derived systemic influence of Klotho on growth development and life span. Furthermore, it would allow the investigation of cell-specific autocrine or paracrine effects of renal Klotho involved in the pathophysiology of CKD-related complications such as interstitial fibrosis and ectopic calcification.
Herein, we generated a novel mouse model with a kidneyspecific Klotho deletion mainly in distal tubular segments and provide genetic evidence favoring a pivotal role of FGF23-Klotho signaling in controlling mineral metabolism.
RESULTS

Generation of
The targeting vector of floxed Klotho mice and genotyping results are shown in Figure 1A . To obtain the desired Klotho deletion, we used Ksp-cadherin-Cre mice, which express Cre exclusively in tubular epithelial cells in the mature and developing kidney and in the developing genitourinary tract. 18 A partial deletion of renal Klotho was confirmed with immunohistochemistry ( Figure 1B ). The relative level of remnant median Klotho transcripts in 15 screened kidney homogenates was 0.69 (range, 0.26-1.0) compared with wild-type controls. Protein levels of Klotho quantified by Western blotting correlated highly to transcript levels ( Figure 1C ).
Gross Phenotype of Adult Ksp-KL 2/2 Mice Ksp-KL 2/2 mice were viable, fertile, and did not differ in size or display any gross physical or behavioral abnormalities (Figure 2 ). There was no correlation between residual Klotho expression and body size.
Generation of b-KL
2/2 Mice To confirm functionality of the floxed Klotho allele, we generated a global deletion of Klotho (b-KL 2/2 ) using mice expressing Cre under the control of the human b-actin promoter. In stark contrast to Ksp-KL 2/2 mice, b-KL 2/2 mice recapitulated the phenotype of existing Klotho null mice, 1 including severe growth retardation, kyphosis, lessened activity, and significantly reduced life span (Figure 2 ). In agreement, b-KL 2/2 mice (n=2, mean 6 SEM) were hyperphosphatemic (5.360.06 mmol/L), hypercalcemic (2.8060.06 mmol/L), with extremely elevated FGF23 levels (234,630630,000 pg/ml) despite normal serum creatinine (44.861.9 mmol/L).
Biochemistries of Ksp-KL
2/2 Mice Serum biochemistries were examined in adult mice at 8 weeks of age ( Figure 3A ). Ksp-KL 2/2 mice were hyperphosphatemic with elevated FGF23. Parathyroid hormone (PTH) was decreased in Ksp-KL 2/2 mice, whereas 1,25(OH) 2 D, calcium, and creatinine levels were unaltered. Urinary calcium excretion was significantly increased as determined by calcium/ creatinine ratio ( Figure 3B ) and fractional excretion of calcium (1.82 versus 0.67; P,0.05), but no difference was found in urinary phosphate/creatinine ratio ( Figure 3B) Figure 3C . Both groups developed hyperphosphatemia, albeit more pronounced in Ksp-KL 2 /2 mice. The FGF23 response to phosphate loading was accentuated in Ksp-KL 2/2 mice. Ksp-KL 2/2 mice had higher PTH, contrasting the reduced PTH level when fed a regular diet ( Figure 3A) . In linear regression analysis, phosphate was the only assessed biochemical parameter that correlated to FGF23 in mice on a regular diet (r 2 =0.29; P,0.01), whereas phosphate (r 2 =0.29, P,0.05) and PTH (r 2 =0.41, P,0.005) correlated with FGF23 in mice on a high phosphate diet. Figure 3D ). No differences in calcium, phosphate, PTH, 1,25(OH) 2 D, or creatinine were noted (Table 1 ). In the same mice, transcript level of Cyp27B1 was increased (P,0.001) with a similar trend for Cyp24A1 (P=0.08).
Comparison of
Serum Biochemistries as a Function of Residual Klotho Expression
Because Klotho was deleted with variable efficacy, we analyzed the Klotho transcript level as a continuous variable. FGF23 was the only serum parameter significantly correlating to Klotho (r 2 =0.23; P,0.05), whereas no correlations were found for phosphate (P=0.09), calcium (P=0.13), PTH (P=0.13), or 1,25(OH) 2 D (P=0.72). To determine possible threshold effects, we screened 15 Ksp-KL 2/2 mice and arbitrarily categorized them into the following three groups based on their residual Klotho level: Klotho level .70% of wild-type counterparts (mean 88%; n=7); Klotho level of 30%-70% (mean 59%; n=6); and Klotho ,30% (mean 28%; n=2). Phosphate and calcium levels gradually increased, whereas PTH levels decreased with lower Klotho expression ( Table  2) . In contrast, a marked threshold effect was established for FGF23 when relative Klotho expression was ,30%, leading to levels 30-250 times higher than in wild-type mice ( Figure 4 ).
Histology
No differences were found with regard to general renal morphology, calcifications, or fibrosis in Ksp-KL 2/2 mice ( Figure 5 ). The parathyroid glands were grossly normal with similar Klotho expression as in wild-type mice (data not shown). In contrast, b-KL 2/2 mice had reduced kidney size and cortex height, higher cell density, extensive vascular and tubular calcifications, and slightly increased fibrosis compared with wild-type mice ( Figure 5 ).
Renal Protein Expression
Immunohistochemical analysis revealed abundant expression of Npt2a at the brush border membrane in Ksp-KL 2/2 mice compared with wild-type controls. The vitamin D receptor (VDR) had a more heterogeneous pattern in Ksp-KL 2/2 mice. There was no difference in cell proliferation rate as determined by Ki67 index (1.0% versus 0.95%; P=0.66; n$5 of each genotype) ( Figure 6A ).
Dual immunofluorescence staining in wild-type mice showed that Klotho predominantly colocalized with the distal tubuli marker TRPV5, and very weakly with the proximal marker Npt2a. A similar pattern of residual Klotho protein was found in Ksp-KL 2/2 mice. The signal intensity of Klotho in the proximal tubuli appeared unaltered in Ksp-KL 2/2 compared with wild-type mice, confirming a distal rather than proximal deletion of Klotho ( Figure 6B ).
Western blotting showed increased VDR and decreased TRPV5 protein in Ksp-KL 2/2 mice ( Figure 6C ). However, immunostaining did not show a cell-specific downregulation of TRPV5 in the tubular segments where Klotho was deleted ( Figure 6B ).
Renal Gene Expression
Transcript level of renal Cyp27B1 was increased in Ksp-KL 2/2 mice, whereas VDR, Npt2a, Npt2c, FGFR1, CaSR, and TRPV5 were unaltered (Table 3 ). Significant correlations were found between Klotho and Cyp27B1, VDR, Npt2a, and FGFR1 (Figure 7A) . Renal transcript levels of mice challenged with a high phosphate diet are also shown in Table 3 . Similarly, Cyp27B1 expression was higher in Ksp-KL 2/2 mice whereas VDR, Npt2a, and CaSR were reduced. The correlations between Klotho to VDR and Npt2a were strengthened by dietary phosphate loading ( Figure 7B ).
DISCUSSION
We present a novel mouse model (Ksp-KL
2/2
) harboring a partial deletion of Klotho predominantly in distal tubular segments of the kidney, demonstrating a pivotal role of Klotho in regulation of mineral metabolism. Ksp-KL 2/2 mice provide additional valuable information compared with general Klotho null mice. First, the variable efficacy of Klotho deletion allowed testing for potential dose-dependent effects, revealing a graded increase in serum phosphate and FGF23 levels with lower Klotho levels, corroborating with the established phosphaturic action of FGF23-Klotho. There was also a trend toward an increase in serum calcium level that paralleled the Klotho reduction. The reason for this remains unclear, especially given that fractional excretion of calcium was increased and PTH somewhat lower in Ksp-KL 2/2 compared with wild-type mice. One explanation may be a functional increase in VDR signaling because VDR protein was quantitatively increased in the face of an unaltered systemic 1,25(OH) 2 D level. We also found it rather surprising that the 1,25(OH) 2 D level remained normal given that FGF23-Klotho signaling is a counter-regulatory hormone system for 1,25(OH) 2 D. Mechanistically, there was an increase in Cyp27B1 and a borderline significant increase in Cyp24A1 at the transcript level, which presumably translates into both an increased synthesis and degradation of active vitamin D. The rise in Cyp27B1 is in agreement with attenuated FGF23-Klotho 16 which simply cannot be attributed to differences in the circulating mineral metabolites. However, this study is clearly limited in terms of investigating the dynamics of FGF23-Klotho in early CKD, and this important question should be addressed in future studies.
A fundamental question is how a renal FGF23 resistance due to Klotho deficiency translates into increased FGF23 production in bone. Secondary changes in mineral metabolism, including hyperphosphatemia, are plausible. Indeed, we found a gradual rise in serum phosphate and FGF23 with declining Klotho levels, and dietary phosphate loading 19 or interact with other yet unidentified FGF23 regulatory elements. These possibilities need to be explored in additional experimental studies.
In contrast to general Klotho null mice, Ksp-KL 2/2 mice had a normal growth development and did not differ in body size compared with wild-type littermates. This contradicts that renal Klotho insufficiency causes systemic toxicity, although it may also be explained by the incomplete knockout efficacy (i.e., the residual Klotho amounts are sufficient to maintain a normal growth status and body weight). Similarly, the biochemical abnormalities in Ksp-KL 2/2 mice may be too subtle to evoke systemic toxicity as in general Klotho null mice, favored by previous studies showing that a low calcium-and phosphate-containing rescue diet attenuates the phenotype in animal models of absent FGF23-Klotho signaling 11 Another distinct difference compared with general Klotho null mice is the absence of overt renal abnormalities such as interstitial fibrosis and ectopic calcifications in Ksp-KL 2/2 mice. This was unexpected given that Klotho has been implicated as an antifibrotic agent by blocking TGF-b signaling 20 and by acting as an endogenous inhibitor of vascular calcification. 15 This argues against dominant cell-specific autocrine or paracrine effects of renal tubular Klotho, at least in the short term. Additional long-term studies are warranted to determine whether renal-specific Klotho deletion affects these phenotypes, especially in CKD.
Both FGF23 and PTH are phosphaturic hormones, acting on the same phosphate transporters in the kidney, namely Npt2a and Npt2c. 7, 21, 22 In the face of hyperphosphatemia, serum PTH was suppressed, whereas FGF23 was increased in Ksp-KL 2/2 mice on a regular diet, suggesting that FGF23 may either respond earlier or play a more dominant role than PTH in regulating phosphate transport during chronic hyperphosphatemia. The reduction in PTH found in Ksp-KL 2/2 mice could could either be caused by higher systemic calcium levels or the fact that FGF23 inhibits PTH synthesis and secretion by directly targeting the parathyroid glands. 23, 24 In contrast, Ksp-KL 2/2 mice challenged with a high-phosphate diet had higher PTH than wild-type littermates. The underlying mechanisms remain unclear. One possibility is that parathyroid Klotho expression is differentially regulated in Ksp-KL 2/2 mice and that dietary phosphate loading evokes a Klotho-dependent parathyroid FGF23 resistance. Irrespectively, this phenomenon may represent a rescue mechanism against phosphate toxicity when FGF23 signaling is inappropriately low in relation to the degree of phosphate challenge. The proximal tubule is the principal site for renal phosphate reabsorption. 22 In agreement with a previous report, we found that Klotho expression is largely confined to the distal tubules 3 and that the Cre recombination driven by the Kspcadherin promoter is functional mainly in distal tubular cells. Although immunofluorescence staining suggested a low Klotho expression also in proximal segments, it is still likely that distal Klotho plays an important role in proximal phosphate transport.
Hyperphosphatemic Ksp-KL 2/2 mice had increased Npt2a protein expression at the brush-border membrane. In contrast, the Npt2a transcript level was positively correlated to the renal Klotho, indicating uncoupling of Npt2a transcription to translation. Because the observed reduction in the Npt2a transcript level is an adequate compensatory response to hyperphosphatemia, our data suggest that dismantling of renal FGF23-Klotho signaling may result in aberrant Npt2a protein processing or degradation rather than transcriptional dysregulation. A similar uncoupling, possibly an adaptive response, was observed for VDR.
Urinary calcium excretion was increased in Ksp-KL 2/2 mice consistent with the known action of renal Klotho from previous in vitro studies 2 and the observed reduction in TRPV5 protein. In contrast, we did not detect any difference in urinary phosphate excretion despite hyperphosphatemia and increased abundance of Npt2a in Ksp-KL 2/2 mice. We speculate that this may be due to intermittent periods of hypophosphaturia that were not captured by our spot urinary analysis.
In summary, deletion of Klotho in distal tubular segments reveals a fundamental role of Klotho in renal homeostatic control of mineral metabolism and as a determinant of circulating FGF23.
CONCISE METHODS
Generation of Kidney-Specific Klotho Knockout Mice
Mice with a kidney-specific Klotho deletion were generated using Cre-Lox recombination. Briefly, the sequence of mouse chromosome 5 ) served as wild-type controls. To minimize the intralitter variability, mice were intercrossed, making 50% of the offspring kidney-specific Klotho null mice and 50% controls that were subsequently analyzed. Mice with a systemic Klotho deletion were generated using mice expressing Cre under the human b-actin promotor (FVB/N-Tg(ACTB-cre)2Mrt/J, Jackson Laboratory). Generation of the targeting vector, cloning, and electroporation into embryonic stem cells was carried out by Caliper Life Sciences (Hopkinton, MA).
Genotyping
Total DNA was extracted from tail biopsies using DirectPCR Lysis Reagent (Viagen, Los Angeles, CA). PCR amplification was carried out on a 2720 Thermal Cycler (Applied Biosystems, Carlsbad, CA) using HotStarTaq DNA Polymerase (Qiagen, Venlo, Netherlands). The PCR products were visualized on a 1% agarose gel with GelRed Nucleic Acid Gel Stain (Biotium, Hayward, CA). Sequences of the primers used for genotyping are listed in Supplemental Table 1 .
Animal Housing
Mice were fed standard rodent chow (RM1; SDS, Essex, UK) containing 0.73% calcium and 0.52% phosphate. In the high phosphate experiment mice were fed a diet containing 1.0% calcium and 1.65% phosphate (TD.88345; Harlan Laboratories, Indianapolis, IN) for 10 days, starting at 8 weeks of age. Blood sampling was performed by tail vein incision at intermediate time points and by bleeding the axillary artery at sacrifice. All experiments were conducted in compliance with the guidelines of animal experiments at Karolinska Institutet and approved by the regional ethical board. The correlations between Klotho, VDR, and Npt2a were accentuated in mice on a high phosphate diet. 
